Carlsbad, Calif.-based GenMark produces molecular tests that can identify the presence of several different pathogens, including those that cause COVID-19, from a single sample.
Roche will pay $24.05 per share in an all-cash transaction. The deal is expected to close in 2021’s second quarter.
More articles on pharmacy:
HHS allows retired pharmacists, pharmacy interns to give COVID-19 vaccinations
Sanofi launches trial for 2nd COVID-19 vaccine candidate
Gilead, Merck co-developing long-acting HIV treatment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
